Protara Therapeutics (TARA) Preferred Shares (2018 - 2020)

Protara Therapeutics (TARA) has reported Preferred Shares for 4 consecutive years, with $8.0 the latest figure, recorded in Q3 2020.

• In Q3 2020, Preferred Shares fell 100.0% year-over-year to $8.0; the TTM figure through Sep 2020 stood at $8.0 (down 100.0% YoY), while the FY2019 annual figure was $18.5 million, down 14.22% from the prior year.
• Preferred Shares grew to $8.0 in Q3 2020 per TARA's latest filing, from $4.0 in the prior quarter.
• Across five years, Preferred Shares topped out at $21.5 million in Q4 2017 and bottomed at $4.0 in Q1 2020.
• Historically, Preferred Shares has averaged $14.7 million across 4 years, with a median of $21.2 million in 2019.
• Annual changes were most pronounced in 2018 — Preferred Shares changed 0.0% — and 2020, when it tumbled 100.0%.
• Protara Therapeutics' Preferred Shares stood at $21.5 million in 2017, then changed by 0.0% to $21.5 million in 2018, then retreated by 14.22% to $18.5 million in 2019, then plunged by 100.0% to $8.0 in 2020.
• Business Quant data shows TARA's Preferred Shares at $8.0 in Q3 2020, $4.0 in Q2 2020, and $4.0 in Q1 2020.